Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin

Molecular Carcinogenesis

Volumn 19, Issue 2, 1997, Pages 74-82

  Lepley, Denise M ^a   Pelling, Jill C ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CYCLIN D1; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL CYCLE G1 PHASE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FIBROBLAST; GENE INDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTICARCINOGENIC AGENTS; BLOTTING, WESTERN; CDC2-CDC28 KINASES; CELL CYCLE; CHAMOMILE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FIBROBLASTS; FLAVONOIDS; G0 PHASE; G1 PHASE; G2 PHASE; GENES, RETINOBLASTOMA; HUMANS; OILS, VOLATILE; PHOSPHORYLATION; PLANTS, MEDICINAL; PROTEIN-SERINE-THREONINE KINASES;

EID: 0030796989     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199707)19:2<74::AID-MC2>3.0.CO;2-L     Document Type: Article

References (37)

1. Sherr CJ. G1 phase progression: Cycling on cue. Cell 79:551-555, 1994.
2. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497, 1993.
3. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514, 1992.
4. Peter M, Herskowitz I. Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184, 1994.
5. Liu M, Pelling JC. UV-B/A irradiation of mouse keratinocytes results in p53-mediated WAF1/CIP1 expression. Oncogene 10:1955-1960, 1995.
6. Kern S, Kinzler K, Bruskin A, Friedman JP, Prives C, Vogelstein B. Identification of p53 as a sequence specific DNA binding protein. Science 252:1708-1711, 1991.
7. Zhan Q, Carrier F, Fornace AJ. Induction of cellular p53 activity by DNA damaging agents and growth arrest. Mol Cell Biol 13:4242-4250, 1993.
8. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993.
9. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816, 1993.
10. Harper JW, Elledge SJ, Keyomarsi K, et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6:387-400, 1995.
11. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684, 1995.
12. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV-induced p53 in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128, 1991.
13. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92:8493-8497, 1995.
14. Birt DF, Mitchell D, Gold B, Pour P, Pinch H. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res, in press.
15. 2/M arrest in keratinocytes. Carcinogenesis, in press.
16. 2-M arrest in rat neuronal cells. Biochem. Biophys Res Commun 204:578-584, 1994.
17. An B, Dou QP. Cleavage of retinoblastoma protein during apoptosis: An interleukin 1 β-converting enzyme-like protease as candidate. Cancer Res 56:438-442, 1996.
18. Li Y, Jenkins CW, Nichols MA, Xiong Y. Cell cycle expression and p53-dependent regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261-2268, 1994.
19. Parker S, Eichele G, Zhang P, et al. p53-independent expression of p21CIP1 in muscle and other terminally differentiated cells. Science 267:1024-1027, 1995.
20. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90-98, 1994.
21. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948, 1992.
22. Flagg EW, Coates RJ, Greenberg RS. Epidemiologic studies of antioxidants and cancer in humans. J Am Coll Nutr 14:419-427, 1995.
23. Stavric B. Role of chemopreventers in human diet. Clin Biochem 27:319-332, 1994.
24. Kuo ML, Yang NC. Reversion of v-H-ras transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. Biochem Biophys Res Commun 212:767-775, 1995.
25. Chen X, Bargonetti J, Prives C. p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res 55:4257-4263, 1995.
26. Atadja P, Wong H, Veillete C, Riabowol K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res 217:205-216, 1995.
27. Carlson BA, Dubay MM, Sausville EA, Brizuela L, Worland PJ. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells. Cancer Res 56:2973-2978, 1996.
28. Ewen ME. The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev 13:45-66, 1994.
29. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 81:323-330, 1995.
30. DeGregori J, Kowalik T, Nevins JR. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1/S-regulatory genes. Mol Cell Biol 15:4215-4224, 1995.
31. Losiewicz MD, Carlson BA, Kaur G, Sausville EA, Worland PJ. Potent inhibition of cdc2 kinase activity by the flavonoid L86-8275. Biochem Biophys Res Commun 201:589-595, 1994.
32. WAF1/CIP1 expression by p53-independent pathways. Oncogene 12:1557-1564, 1996.
33. Sheikh MS, Li X, Chen J, Shao Z, Ordonez JV, Fontana JA. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: Role of p53-dependent and independent signal transduction pathways. Oncogene 9:3407-3415, 1994.
34. Shiyanov P, Bagchi S, Adami G, et al. p21 disrupts the interaction between cdk2 and the E2F-130 complex. Mol Cell Biol 16:737-744, 1996.
35. Hainaut P, Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 53:4469-4473, 1993.
36. Takenaka I, Morin F, Seizinger BR, Kley N. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J Biol Chem 270:5405-5411, 1995.
37. Winston JT, Coats SR, Wang Y, Pledger WJ. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12:127-134, 1996.